0001209191-18-015731.txt : 20180302
0001209191-18-015731.hdr.sgml : 20180302
20180302164930
ACCESSION NUMBER: 0001209191-18-015731
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180228
FILED AS OF DATE: 20180302
DATE AS OF CHANGE: 20180302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cancelmi Daniel J
CENTRAL INDEX KEY: 0001396106
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07293
FILM NUMBER: 18662778
MAIL ADDRESS:
STREET 1: 13737 NOEL ROAD
STREET 2: SUITE 100
CITY: DALLAS
STATE: TX
ZIP: 75240
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TENET HEALTHCARE CORP
CENTRAL INDEX KEY: 0000070318
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 952557091
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
BUSINESS PHONE: 469-893-2200
MAIL ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-28
0
0000070318
TENET HEALTHCARE CORP
THC
0001396106
Cancelmi Daniel J
1445 ROSS AVENUE
SUITE 1400
DALLAS
TX
75202
0
1
0
0
Chief Financial Officer
2018 February Restricted Stock Units
2018-02-28
4
A
0
37217
0.00
A
Common Stock
37217
37217
D
2018 February Performance Stock Options (Right to Buy)
20.60
2018-02-28
4
A
0
86826
0.00
A
2028-02-28
Common Stock
86826
86826
D
These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting.
These performance-based stock options vest on the third anniversary of the date of grant, subject to the satisfaction of a stock price performance condition requiring the Company's common stock price to close at or above $25.75 per share for any 20 consecutive trading days during the three-year period following the date of grant.
Anthony L. Shoemaker, as Attorney-in-Fact for Daniel J. Cancelmi
2018-03-02